Pre-, pro-, and synbiotics: Do they have a role in reducing uremic toxins? a systematic review and meta-analysis

International Journal of Nephrology

Volumn 2012, Issue , 2012, Pages

  Rossi, Megan ^a,b   Klein, Kerenaftali ^a   Johnson, David W ^a,b   Campbell, Katrina L ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872158044     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2012/673631     Document Type: Review

References (57)

1. World Health Organisation, Data W. L. C. I. P., The Global Burden of Disease: 2004 Update 2004 Geneva, Switzerland WHO Press
2. Weiner D. E., Tighiouart H., Amin M. G., Stark P. C., Macleod B., Griffith J. L., Salem D. N., Levey A. S., Sarnak M. J., Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. Journal of the American Society of Nephrology 2004 15 5 1307 1315 2-s2.0-1942506539 10.1097/01.ASN.0000123691. 46138.E2 (Pubitemid 38526012)
3. Schepers E., Glorieux G., Vanholder R., The gut: the forgotten organ in Uremia? Blood Purification 2010 29 2 130 136 2-s2.0-77749318546 10.1159/000245639
4. Meijers B. K. I., De Loor H., Bammens B., Verbeke K., Vanrenterghem Y., Evenepoel P., p-cresyl sulfate and indoxyl sulfate in hemodialysis patients. Clinical Journal of the American Society of Nephrology 2009 4 12 1932 1938 2-s2.0-73649142365 10.2215/CJN.02940509
5. Taki K., Tsuruta Y., Niwa T., Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients. American Journal of Nephrology 2007 27 1 30 35 2-s2.0-33847668826 10.1159/000098542 (Pubitemid 46364538)
6. Niwa T., Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120. Therapeutic Apheresis and Dialysis 2011 15 2 120 124 2-s2.0-79953038796 10.1111/j.1744-9987.2010.00882.x
7. Meijers B. K. I., Evenepoel P., The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. Nephrology Dialysis Transplantation 2011 26 3 759 761 2-s2.0-79952154288 10.1093/ndt/gfq818
8. Evenepoel P., Meijers B. K. I., Bammens B. R. M., Verbeke K., Uremic toxins originating from colonic microbial metabolism. Kidney International 2009 76 supplement 114 S12 S19 2-s2.0-71949106205 10.1038/ki.2009.402
9. Evenepoel P., Claus D., Geypens B., Hiele M., Geboes K., Rutgeerts P., Ghoos Y., Amount and fate of egg protein escaping assimilation in the small intestine of humans. American Journal of Physiology 1999 277 5 G935 G943 2-s2.0-0032740382
10. Lin C. J., Chen H. H., Pan C. F., Chuang C. K., Wang T. J., Sun F. J., Wu C. J., p-cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease. Journal of Clinical Laboratory Analysis 2011 25 3 191 197 2-s2.0-79955883106 10.1002/jcla.20456
11. Gibson G., Scott K., Rastall R., Dietary Prebitoics: current status and new defintion. IFIS Functional Foods Bulletin 2010 7 1 1 19 10.1616/1476-2137. 15880
12. National Health and Medical Research Council Guideline Assessment Register Consultants, NHMRC Levels of Evidence and Grades for Recommendations for Developers of Guidelines 2009 N.H.A.M.R. Council
13. Uhlig K., MacLeod A., Craig J., Lau J., Levey A. S., Levin A., Moist L., Steinberg E., Walker R., Wanner C., Lameire N., Eknoyan G., Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International 2006 70 12 2058 2065 2-s2.0-33845343267 10.1038/sj.ki.5001875 (Pubitemid 44871367)
14. Wishart D. S., Tzur D., Knox C., Human Metabolome Database 2009 Canada Genome Alberta & Genome
15. Vanholder R., Bammens B., De Loor H., Glorieux G., Meijers B., Schepers E., Massy Z., Evenepoel P., Warning: the unfortunate end of p-cresol as a uraemic toxin. Nephrology Dialysis Transplantation 2011 26 5 1464 1467 2-s2.0-79955629385 10.1093/ndt/gfr056
16. R Development Core Team, R: A Language and Environment for Statistical Computing 2011 R Foundation for Statistical Computing
17. Viechtbauer W., Conducting meta-analyses in R with the metafor. Journal of Statistical Software 2010 36 3 1 48 2-s2.0-77958110812
18. Cloetens L., Broekaert W. F., Delaedt Y., Ollevier F., Courtin C. M., Delcour J. A., Rutgeerts P., Verbeke K., Tolerance of arabinoxylan- oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study. British Journal of Nutrition 2010 103 5 703 713 2-s2.0-77949512191 10.1017/S0007114509992248
19. De Preter V., Vanhoutte T., Huys G., Swings J., Rutgeerts P., Verbeke K., Baseline microbiota activity and initial bifidobacteria counts influence responses to prebiotic dosing in healthy subjects. Alimentary Pharmacology and Therapeutics 2008 27 6 504 513 2-s2.0-39749160044 10.1111/j.1365-2036.2007. 03588.x (Pubitemid 351300850)
20. Ito M., Kimura M., Deguchi Y., Miyamori-Watabe A., Yajima T., Kan T., Effects of transgalactosylated disaccharides on the human intestinal microflora and their metabolism. Journal of Nutritional Science and Vitaminology 1993 39 3 279 288 10.3177/jnsv.39.279
21. Ito M., Deguchi Y., Matsumoto K., Kimura M., Onodera N., Yajima T., Influence of galactooligosaccharides on the human fecal microflora. Journal of Nutritional Science and Vitaminology 1993 39 6 635 640 10.3177/jnsv.39.635
22. Terada A., Hara H., Kataoka M., Mitsuoka T., Effect of lactulose on the composition and Metabolic Activity of the Human Faecal Flora. Microbial Ecology in Health and Disease 1992 5 1 43 50
23. Geboes K. P., De Hertogh G., De Preter V., Luypaerts A., Bammens B., Evenepoel P., Ghoos Y., Geboes K., Rutgeerts P., Verbeke K., The influence of inulin on the absorption of nitrogen and the production of metabolites of protein fermentation in the colon. British Journal of Nutrition 2006 96 6 1078 1086 2-s2.0-33947547494 10.1017/BJN20061936 (Pubitemid 46470171)
24. Alles M. S., Hartemink R., Meyboom S., Harryvan J. L., Van Laere K. M. J., Nagengast F. M., Hautvast J. G. A. J., Effect of transgalactooligosaccharides on the composition of the human intestinal microflora and on putative risk markers for colon cancer. American Journal of Clinical Nutrition 1999 69 5 980 991 2-s2.0-0032962880 (Pubitemid 29205074)
25. Ling W. H., Korpela R., Mykkanen H., Salminen S., Hanninen O., Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. Journal of Nutrition 1994 124 1 18 23 2-s2.0-0028147437 (Pubitemid 24057432)
26. Tohyama K., Kobayashi Y., Kan T., Effect of lactobacilli on urinary indican excretion in gnotobiotic rats and in man. Microbiology and Immunology 1981 25 2 101 112 2-s2.0-0019434381 (Pubitemid 11116343)
27. Fujiwara S., Seto Y., Kimura A., Hashiba H., Establishment of orally-administered Lactobacillus gasseri SBT2055SR in the gastrointestinal tract of humans and its influence on intestinal microflora and metabolism. Journal of Applied Microbiology 2001 90 3 343 352 2-s2.0-0035106851 10.1046/j.1365-2672.2001.01251.x (Pubitemid 32221527)
28. De Preter V., Coopmans T., Rutgeerts P., Verbeke K., Influence of long-term administration of lactulose and Saccharomyces boulardii on the colonic generation of phenolic compounds in healthy human subjects. Journal of the American College of Nutrition 2006 25 6 541 549 2-s2.0-33846592721 (Pubitemid 46175669)
29. 4]tyrosine to assess the effects of pro- and prebiotics on the intestinal flora of healthy human volunteers. British Journal of Nutrition 2004 92 3 439 446 2-s2.0-6944251246 10.1079/BJN20041228 (Pubitemid 40282546)
30. De Preter V., Vanhoutte T., Huys G., Swings J., De Vuyst L., Rutgeerts P., Verbeke K., Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. American Journal of Physiology 2007 292 1 G358 G368 2-s2.0-33846156865 10.1152/ajpgi.00052.2006 (Pubitemid 46090279)
31. Swanson K. S., Grieshop C. M., Flickinger E. A., Bauer L. L., Wolf B. W., Chow J., Garleb K. A., Williams J. A., Fahey G. C., Jr, Fructooligosaccharides and Lactobacillus acidophilus modify bowel function and protein catabolites excreted by healthy humans. Journal of Nutrition 2002 132 10 3042 3050 2-s2.0-0036790049
32. Meijers B. K. I., De Preter V., Verbeke K., Vanrenterghem Y., Evenepoel P., P-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. Nephrology Dialysis Transplantation 2010 25 1 219 224 2-s2.0-72949119718 10.1093/ndt/gfp414
33. Takayama F., Taki K., Niwa T., Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis. American Journal of Kidney Diseases 2003 41 3 S142 S145 2-s2.0-0037374177 (Pubitemid 36278365)
34. Taki K., Takayama F., Niwa T., Beneficial effects of Bifidobacteria in a gastroresistant seamless capsule on hyperhomocysteinemia in hemodialysis patients. Journal of Renal Nutrition 2005 15 1 77 80 2-s2.0-11844295977 10.1053/j.jrn.2004.09.028 (Pubitemid 40093687)
35. Hida M., Aiba Y., Sawamura S., Suzuki N., Satoh T., Koga Y., Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oval administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 1996 74 2 349 355 2-s2.0-0029834566 (Pubitemid 26326708)
36. Nakabayashi I., Nakamura M., Kawakami K., Ohta T., Kato I., Uchida K., Yoshida M., Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. Nephrology Dialysis Transplantation 2011 26 3 1094 1098 2-s2.0-79952176810 10.1093/ndt/gfq624
37. Bammens B., Evenepoel P., Verbeke K., Vanrenterghem Y., Impairment of small intestinal protein assimilation in patients with end-stage renal disease: extending the malnutrition-inflammation-atherosclerosis concept. American Journal of Clinical Nutrition 2004 80 6 1536 1543 2-s2.0-16544368215 (Pubitemid 41103850)
38. Bammens B., Verbeke K., Vanrenterghem Y., Evenepoel P., Evidence for impaired assimilation of protein in chronic renal failure. Kidney International 2003 64 6 2196 2203 2-s2.0-0344945427 10.1046/j.1523-1755.2003.00314.x (Pubitemid 37449555)
39. Cummings J. H., Hill M. J., Bone E. S., The effect of meat protein and dietary fiber on colonic function and metabolism. II. Bacterial metabolites in feces and urine. American Journal of Clinical Nutrition 1979 32 10 2094 2101 2-s2.0-0018718884 (Pubitemid 10244807)
40. Geypens B., Claus D., Evenepoel P., Hiele M., Maes B., Peeters M., Rutgeerts P., Ghoos Y., Influence of dietary protein supplements on the formation of bacterial metabolites in the colon. Gut 1997 41 1 70 76 2-s2.0-0030792066 (Pubitemid 27351643)
41. Ling W. H., Hanninen O., Shifting from a conventional diet to an uncooked vegan diet reversibly alters fecal hydrolytic activities in humans. Journal of Nutrition 1992 122 4 924 930 2-s2.0-0026597162
42. Lee C. T., Kuo C. C., Chen Y. M., Hsu C. Y., Lee W. C., Tsai Y. C., Ng H. Y., Kuo L. C., Chiou T. T. Y., Yang Y. K., Cheng B. C., Chen J. B., Factors associated with blood concentrations of Indoxyl sulfate and p-Cresol in patients undergoing peritoneal dialysis. Peritoneal Dialysis International 2010 30 4 456 463 2-s2.0-77955239953 10.3747/pdi.2009.00092
43. Vitetta L., Sali A., Probiotics, prebiotics and gastrointestinal health. Medicine Today 2008 9 9 65 70 2-s2.0-54749140017
44. Sutton D., Dumbleton S., Allaway C., Can increased dietary fibre reduce laxative requirement in peritoneal dialysis patients? Journal of Renal Care 2007 33 4 174 178 2-s2.0-38549119816
45. Wang H. F., Lim P. S., Kao M. D., Chan E. C., Lin L. C., Wang N. P., Use of isomalto-oligosaccharide in the treatment of lipid profiles and constipation in hemodialysis patients. Journal of Renal Nutrition 2001 11 2 73 79 2-s2.0-0035316850 10.1053/jren.2001.22485 (Pubitemid 33601534)
46. Den Hond E., Geypens B., Ghoos Y., Effect of high performance chicory inulin on constipation. Nutrition Research 2000 20 5 731 736 2-s2.0-0034193792 10.1016/S0271-5317(00)00162-7 (Pubitemid 30317216)
47. Hasler C. M., Functional foods: their role in disease prevention and health promotion. Food Technology 1998 52 11 63 70 2-s2.0-0001891097 (Pubitemid 128593781)
48. Campbell K. L., Ash S., Bauer J. D., Davies P. S. W., Evaluation of nutrition assessment tools compared with body cell mass for the assessment of malnutrition in chronic kidney disease. Journal of Renal Nutrition 2007 17 3 189 195 2-s2.0-34247207192 10.1053/j.jrn.2006.12.005 (Pubitemid 46617293)
49. Heimbürger O., Qureshi A. R., Blaner W. S., Berglund L., Stenvinkel P., Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. American Journal of Kidney Diseases 2000 36 6 1213 1225 2-s2.0-0033653520
50. Campbell K., Campbellm K., MacLaughlin H., Evidence based practice guidelines for the nutritional management of chronic kidney disease. Nutrition & Dietetics 2007 63 supplement 2 S33 S45
51. Mitsubishi Tanabe Pharma Corporation, A Study of AST-120 For Evaluating Prevention of Progression in Chronic Kidney Disease (EPPIC-1) 2011
52. Nakamura T., Kawagoe Y., Matsuda T., Ueda Y., Shimada N., Ebihara I., Koide H., Oral adsorbent AST-120 decreases carotid intima-media thickness and arterial stiffness in patients with chronic renal failure. Kidney and Blood Pressure Research 2004 27 2 121 126 2-s2.0-2342564944 10.1159/000077536 (Pubitemid 38594564)
53. Yu M., Kim Y. J., Kang D. H., Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress. Clinical Journal of the American Society of Nephrology 2011 6 1 30 39 2-s2.0-79251528072 10.2215/CJN.05340610
54. Sanaka T., Akizawa T., Koide K., Koshikawa S., Clinical analysis of renoprotective responding patients administrated with oral adsorbent in chronic renal failure secondary to chronic glomerulonephritis. Therapeutic Apheresis 2003 7 2 269 278 2-s2.0-0037631734 10.1046/j.1526-0968.2003.00024.x (Pubitemid 36753928)
55. Ueda H., Shibahara N., Takagi S., Inoue T., Katsuoka Y., AST-120, an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases. Therapeutic Apheresis and Dialysis 2007 11 3 189 195 2-s2.0-34248194989 10.1111/j.1744-9987.2007.00430.x (Pubitemid 46716161)
56. Yorioka N., Ito T., Masaki T., Ogata S., Asakimori Y., Tanji C., Kyuden Y., Komiya Y., Kumagai J., Taniguchi Y., Kohno N., Dose-independent effect of an oral adsorbent, AST-120, in patients with early chronic renal failure. Journal of International Medical Research 2002 30 5 467 475 2-s2.0-0036754598 (Pubitemid 35282671)
57. Owada A., Nakao M., Koike J., Ujiie K., Tomita K., Shiigai T., Effects of oral adsorbent AST-120 on the progression of chronic renal failure: a randomized controlled study. Kidney International, Supplement 1997 51 63 S188 S190 2-s2.0-0031460218 (Pubitemid 28020467)